CA-A Cancer Journal for Clinicians

Papers
(The TQCC of CA-A Cancer Journal for Clinicians is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries57588
Cancer Statistics, 202111865
Cancer statistics, 202210817
Cancer statistics, 20236385
Cancer treatment and survivorship statistics, 20221110
Current treatment and recent progress in gastric cancer844
Breast Cancer Statistics, 2022804
Colorectal cancer statistics, 2023658
Cancer statistics for adolescents and young adults, 2020619
Treatment of muscle‐invasive and advanced bladder cancer in 2020535
Cancer statistics, 2024496
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society484
Brain and other central nervous system tumor statistics, 2021461
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations402
Metabolomics in cancer research and emerging applications in clinical oncology309
American Cancer Society nutrition and physical activity guideline for cancer survivors280
Cancer statistics for African American/Black People 2022269
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma254
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries253
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions249
Clinical management of metastatic colorectal cancer in the era of precision medicine203
Cancer statistics for the US Hispanic/Latino population, 2021194
Integrative oncology: Addressing the global challenges of cancer prevention and treatment166
Radiation therapy‐associated toxicity: Etiology, management, and prevention158
158
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies157
Molecular imaging in oncology: Current impact and future directions132
A systematic review of rehabilitation and exercise recommendations in oncology guidelines123
American Cancer Society's report on the status of cancer disparities in the United States, 2021122
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians112
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions104
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation97
An update on the immune landscape in lung and head and neck cancers95
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach92
Cervical cancer prevention and control in women living with human immunodeficiency virus87
86
Onconephrology: The intersections between the kidney and cancer81
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer80
Intermittent fasting in the prevention and treatment of cancer79
77
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward76
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer74
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies70
Cancer epigenetics in clinical practice67
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review65
60
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer55
Recent progress in the treatment of cancer in children54
Blueprint for cancer research: Critical gaps and opportunities53
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions51
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians50
The contemporary management of cancers of the sinonasal tract in adults46
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature45
Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee44
An overview of real‐world data sources for oncology and considerations for research44
Current and future cancer staging after neoadjuvant treatment for solid tumors38
Critical care management of chimeric antigen receptor T‐cell therapy recipients36
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer35
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice35
0.85802602767944